Skip to main content
Back to Kleiner Perkins

Kleiner Perkins's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Kleiner Perkins. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$272.5M

Pharmaceutical Portfolio Companies (5)

Export
Health CareMedicalPharmaceutical

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.

San Francisco, United States
June 2026
$2.5M
Grant

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceuticalSoftware

Biogenesis is building the end-to-end platform for clinical research.

Palo Alto, United States
March 2024
$2.5M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

South San Francisco, United States
October 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Hsinchu, Taiwan
October 2018
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Zephyr Health operates as an insights-as-a-service solution built specifically for life sciences companies.

San Francisco, United States
August 2015
$17.5M
Series C

Founder Contacts

30,000+ verified contacts

Explore Kleiner Perkins's Full Portfolio

View all companies funded by Kleiner Perkins across every industry and funding stage.

View Full Kleiner Perkins Portfolio